Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15268715rdf:typepubmed:Citationlld:pubmed
pubmed-article:15268715lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:15268715lifeskim:mentionsumls-concept:C0206730lld:lifeskim
pubmed-article:15268715lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:15268715lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:15268715pubmed:issue8lld:pubmed
pubmed-article:15268715pubmed:dateCreated2004-7-22lld:pubmed
pubmed-article:15268715pubmed:abstractTextIt is generally accepted that the two types of neurothekeoma (myxoid type and cellular type) represent the two poles of a spectrum. This concept, however, has recently been challenged, and cellular neurothekeomas have been suggested as a separate classification and are included in the "fibrohistiocytic" category by some authors. Cellular neurothekeomas have been reported to show negative immunohistochemical staining for histiocytic markers, and PG-M1 is now considered to be the most reliable histiocytic marker.lld:pubmed
pubmed-article:15268715pubmed:languageenglld:pubmed
pubmed-article:15268715pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15268715pubmed:citationSubsetIMlld:pubmed
pubmed-article:15268715pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15268715pubmed:statusMEDLINElld:pubmed
pubmed-article:15268715pubmed:monthSeplld:pubmed
pubmed-article:15268715pubmed:issn0303-6987lld:pubmed
pubmed-article:15268715pubmed:authorpubmed-author:SatohToshimiTlld:pubmed
pubmed-article:15268715pubmed:authorpubmed-author:MisagoNoriyuk...lld:pubmed
pubmed-article:15268715pubmed:authorpubmed-author:NarisawaYutak...lld:pubmed
pubmed-article:15268715pubmed:issnTypePrintlld:pubmed
pubmed-article:15268715pubmed:volume31lld:pubmed
pubmed-article:15268715pubmed:ownerNLMlld:pubmed
pubmed-article:15268715pubmed:authorsCompleteYlld:pubmed
pubmed-article:15268715pubmed:pagination568-72lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:meshHeadingpubmed-meshheading:15268715...lld:pubmed
pubmed-article:15268715pubmed:year2004lld:pubmed
pubmed-article:15268715pubmed:articleTitleCellular neurothekeoma with histiocytic differentiation.lld:pubmed
pubmed-article:15268715pubmed:affiliationDivision of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, Nabeshima 5-1-1, Saga 849-8501, Japan. misago@post.saga-med.ac.jplld:pubmed
pubmed-article:15268715pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15268715pubmed:publicationTypeCase Reportslld:pubmed